Navigation Links
Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
Date:5/8/2008

MIAMI, May 8 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world and a recognized leader in motion preservation technology, today announced the completion of enrollment in its SECURE(R)-C Cervical Artificial Disc IDE study. The SECURE(R)-C device is designed to mimic the normal motion of the spine in order to alleviate pain and restore function as an alternative to fusion in the treatment of symptomatic cervical disc disease. A total of 380 patients have been enrolled in the trial.

"The SECURE(R)-C implant was designed specifically to mimic the physiologic behavior of the natural healthy spine," said Dr. Joseph M. Marzluff M.D., a neurosurgeon in Charleston, SC, who has enrolled dozens of patients in the trial. "The device is a significant breakthrough in treating patients, offering distinct advantages over currently available devices and a simple surgical technique that is easier than traditional plate and screw insertion. We can clearly see the clinical advantages of restoring motion to the cervical spine with our patients, particularly with the device's unique articulating surfaces and translation feature that helps them to regain previously limited motion."

Kelly Baker, Ph.D., Director of Clinical Affair and Regulatory, adds, "Completion of enrollment in our first IDE is further validation of our unique product development and regulatory process and will set the stage for our extensive efforts in motion preservation. We are extremely grateful to our dedicated investigators and staff as their contributions have been critical to successful completion of enrollment. We look forward to continued patient follow-up, and PMA submission for ultimate market entry within the next two years."

Globus plans to initiate two more US IDE clinical trials this year on motion preservation devices. Three of the company's posterior motion preservation technologies (none of which are currently available in the United States): the TRIUMPH(TM) Posterolateral Disc, the TRANSITION(TM) Posterior Dynamic Stabilization System, and the FLEXUS(TM) Inspinous Process Spacer System are among the numerous research posters and presentations concerning the Company's products at this week's Spine Arthroplasty Society (SAS) meeting in Miami, Florida.

About Globus Medical, Inc.

Globus Medical, Inc. the largest privately held spinal implant manufacturer in the world is based in Audubon, PA. The privately held company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to employ both fusion and non-fusion solutions to promote healing in patients with spinal disorders. Globus Medical has a full portfolio of spinal fusion products, burgeoning initiatives in biomaterials development and minimally invasive approaches, and is among the world leaders in the development of motion preservation technology. Additional information can be accessed at http://www.globusmedical.com.


'/>"/>
SOURCE Globus Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Globus Medical Raises $110 Million in Series E Financing Round
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... N.C. , Feb. 11, 2016 ... leading provider of custom manufacturing and development services ... expanded sterile fill-finish capabilities and capacity in its ... growth in demand has driven several recent investments. ... 2001 it had one filling line with small-scale ...
(Date:2/11/2016)... de fevereiro de 2016  A Proliant Biologicals ... de soroalbumina bovina (BSA -- Bovine Serum ... na Ilha Norte da Nova Zelândia, em Feilding. ... na fábrica da Proliant nos EUA, localizada em ... e instalação dos equipamentos foram feitos de forma ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets ... (APAC) breast cancer market will experience considerable expansion ... at a Compound Annual Growth Rate (CAGR) of 8.5%. ... - states that the Asia-Pacific ... billion in 2014 to $3.4 billion by 2021, at a ...
Breaking Medicine Technology:
(Date:2/12/2016)... Aliso Viejo, CA (PRWEB) , ... February 12, 2016 , ... ... by Pixel Film Studios. The new cartoon style themes are great for showcasing pictures, ... with completely customized scene generators, titles like introductions, lower thirds, transitions and a beautiful ...
(Date:2/11/2016)... ... 11, 2016 , ... According to an article published February 1st ... dietary supplement, is being recalled due to the discovery that it contains dangerous adulterants. ... a single supplement on the market proven to help people safety lose excess weight, ...
(Date:2/11/2016)... ... 11, 2016 , ... Florida Hospital presents Heart Health Awareness night on Sunday ... at the Amalie Arena. The puck drops at 6:00pm, but fans will have the ... prior to the game. The MEGA Heart will be located on Ford Thunder Alley ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall ... been gearing up for their simultaneous grand openings in March. All seven practices ... that you’re probably wondering, is reversing diabetes possible? According to this 2011 CNN ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... clinical decision support technology, with highly adaptable algorithms, has been updated to help ... has signs and symptoms consistent with Zikas and a travel history to affected ...
Breaking Medicine News(10 mins):